Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeted anti bacterial therapy.

Iftach Yacoby1, Itai Benhar

  • 1Department of Molecular Microbiology and Biotechnology, The George S. wise faculty of Life Sciences, Ramat Aviv 69978, Israel.

Infectious Disorders Drug Targets
|September 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Structural modifications of the tumor necrosis factor-α inhibitor Enbrel affect its therapeutic efficacy in a mouse model of rheumatoid arthritis.

The Journal of pharmacology and experimental therapeutics·2026
Same author

Controlling Supramolecular Assembly through Peptide Chirality.

ACS applied materials & interfaces·2025
Same author

Evaluating the Therapeutic Efficacy of an Anti-BAFF Receptor Antibody Using a Rheumatoid Arthritis Mouse Model.

Antibodies (Basel, Switzerland)·2025
Same author

The power of microbial life for the transformation towards a sustainable planet: key messages from the 2024 IUMS Congress in Florence, the city of the Renaissance.

microLife·2025
Same author

Using Combination therapy to overcome diverse challenges of Immune Checkpoint Inhibitors treatment.

International journal of biological sciences·2024
Same author

Antibody Isolation from Human Synthetic Libraries of Single-Chain Antibodies and Analysis Using NGS.

Methods in molecular biology (Clifton, N.J.)·2023
Same journal

Cross-System Transcriptomics Suggests Enterovirus A71 Exploits Wound Healing Programs to Target Neural Progenitors in Human Spinal Cord Organoids.

Infectious disorders drug targets·2026
Same journal

Harnessing the Power of Chinese Essential Oils: A Systematic Review on Holistic Approach to Acne Treatment and Anti-Aging Therapy.

Infectious disorders drug targets·2026
Same journal

Diagnosis of Skin Parasites, Bacteria, and Fungi and Their Impact on Hematological Parameters in Patients with T-LGL Leukemia.

Infectious disorders drug targets·2026
Same journal

The Effective Dosing Schedule of Sodium Bicarbonate for Improving pH in Patients with Metabolic Acidosis.

Infectious disorders drug targets·2026
Same journal

Field Cancerization of the Cervix and Vulva in a Young HIV-Positive Woman: Diagnostic Challenges in Multifocal HPV Disease - A Case Report and Literature Review.

Infectious disorders drug targets·2026
Same journal

A Randomized Clinical Trial Evaluating Antimicrobial Effectiveness of a New Licorice Oral Gel against Salivary Streptococcus mutans.

Infectious disorders drug targets·2026
See all related articles

The rise of antibiotic resistance necessitates novel antimicrobial agents. Targeted delivery platforms can repurpose potent compounds by enhancing selectivity for bacterial targets, overcoming host toxicity.

Area of Science:

  • Microbiology
  • Pharmacology
  • Drug Discovery

Background:

  • Antibiotic resistance is a growing global health crisis, demanding new antimicrobial strategies.
  • Existing antibiotics face limitations due to resistance and host toxicity.
  • Novel antimicrobial agents require distinct mechanisms of action or cellular targets.

Purpose of the Study:

  • To review methods for targeted antimicrobial delivery.
  • To explore the potential of repurposing potent but non-selective antimicrobial compounds.
  • To highlight the emerging field of targeted antibacterial therapies.

Main Methods:

  • Review of current literature on antimicrobial resistance and drug development.
  • Analysis of targeted delivery platforms, including antibody-drug conjugates and non-antibody based moieties.

Related Experiment Videos

  • Exploration of genomic sequencing for novel antimicrobial target identification.

    • Main Results:

    • Targeted delivery platforms can overcome the selectivity limitations of potent antimicrobial agents.
    • Non-antibody based targeting moieties (peptides, proteins, carbohydrates) are gaining traction.
    • Genomic approaches are identifying new antimicrobial targets and compounds.

    Conclusions:

    • Targeted antimicrobial therapy represents a promising strategy to combat resistance.
    • Repurposing existing potent compounds via targeted delivery is a viable approach.
    • Further research into diverse targeting moieties and applications is warranted.